RE:RE:RE:RE:Maybe 20 000 shares here is a reasonable risk eh
Yea ten years ago I thought $6 billion buyout or about $30/sh was doable, and still is though the share count increase dilutes to $20/sh to get to $6 billion. +$20 billion buyout (or $60/sh) is still quite plausible considering all the cancer indications this technology could eventually be applied to. Lung, breast, prostate, colo-rectal, brain, esophageal, kidney etc. However that would require another 3 to 5 years to prove it up. At 65 years old, give me $5~$10/ shares this week and I'll go happily to the farm.